Matches in Wikidata for { <http://www.wikidata.org/entity/Q79112287> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q79112287 description "assaig clínic" @default.
- Q79112287 description "clinical trial" @default.
- Q79112287 description "clinical trial" @default.
- Q79112287 description "clinical trial" @default.
- Q79112287 description "clinical trial" @default.
- Q79112287 description "ensaio clínico" @default.
- Q79112287 description "ensayo clínico" @default.
- Q79112287 description "ensayu clínicu" @default.
- Q79112287 description "essai clinique" @default.
- Q79112287 description "klinisch onderzoek" @default.
- Q79112287 description "клінічне випробування" @default.
- Q79112287 description "կլինիկական փորձարկում" @default.
- Q79112287 name "Efficacy and Safety of Gefapixant (MK-7264) in Women With Chronic Cough and Stress Urinary Incontinence (MK-7264-042)" @default.
- Q79112287 name "Efficacy and Safety of Gefapixant (MK-7264) in Women With Chronic Cough and Stress Urinary Incontinence (MK-7264-042)" @default.
- Q79112287 type Item @default.
- Q79112287 label "Efficacy and Safety of Gefapixant (MK-7264) in Women With Chronic Cough and Stress Urinary Incontinence (MK-7264-042)" @default.
- Q79112287 label "Efficacy and Safety of Gefapixant (MK-7264) in Women With Chronic Cough and Stress Urinary Incontinence (MK-7264-042)" @default.
- Q79112287 prefLabel "Efficacy and Safety of Gefapixant (MK-7264) in Women With Chronic Cough and Stress Urinary Incontinence (MK-7264-042)" @default.
- Q79112287 prefLabel "Efficacy and Safety of Gefapixant (MK-7264) in Women With Chronic Cough and Stress Urinary Incontinence (MK-7264-042)" @default.
- Q79112287 P1050 Q79112287-89354CAA-3B3B-4E33-9265-9D967AE1D25E @default.
- Q79112287 P1050 Q79112287-E40DEB70-99F3-443A-A47F-7FF89C65D970 @default.
- Q79112287 P1132 Q79112287-B9C31D4B-B0A4-4A12-92E5-A0E4059EA4E7 @default.
- Q79112287 P1476 Q79112287-61F39E09-70EC-4B10-BAA2-DC66A1D27B9C @default.
- Q79112287 P2899 Q79112287-76E00478-6337-4CF5-859E-38A238B00340 @default.
- Q79112287 P3098 Q79112287-BEB14CD6-800D-401A-960C-4B99A0CD8C58 @default.
- Q79112287 P31 Q79112287-C504A4E9-F78A-478B-9A79-C097A1D34603 @default.
- Q79112287 P580 Q79112287-E0F91888-FF1B-4289-B64E-40C2EAA5E457 @default.
- Q79112287 P582 Q79112287-535D743E-EC7C-48AF-B20F-250785570ADE @default.
- Q79112287 P6099 Q79112287-BBACF34A-583D-4F9A-8ADE-05D32F3942BC @default.
- Q79112287 P8363 Q79112287-62D0F131-70FC-4DDD-A2F5-0C3E8A59C562 @default.
- Q79112287 P1050 Q281490 @default.
- Q79112287 P1050 Q35805 @default.
- Q79112287 P1132 "+380" @default.
- Q79112287 P1476 "A Phase 3b Randomized, Double-blind, Placebo Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Gefapixant in Women With Chronic Cough and Stress Urinary Incontinence" @default.
- Q79112287 P2899 "+18" @default.
- Q79112287 P3098 "NCT04193176" @default.
- Q79112287 P31 Q30612 @default.
- Q79112287 P580 "2020-01-24T00:00:00Z" @default.
- Q79112287 P582 "2021-03-10T00:00:00Z" @default.
- Q79112287 P6099 Q42824827 @default.
- Q79112287 P8363 Q78089383 @default.